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Bisphosphonates are biologically relevant therapeutics for bone disorders and cancer. Reaction of γ-chlorobutyric acid,
phosphorus acid, and phosphorus trichloride without the use of solvent gave the tetrahydrofuranyl-2,2-bisphosphonate sodium
salt (Na2H2L). The Na2H2L was isolated, characterized in solution by 1H, 13C, and 31P NMR spectroscopy and in solid state by
single X-Ray crystallography. The crystal structure showed that the Na2H2L forms in the crystal inﬁnite two-dimensional sheets
stacked one parallel to the other. A comparison of the chelating properties of H2L
2− with similar hydroxyl bisphosphonate ligands
shows that the strength of the Na–O(furanyl/hydroxyl) bond is directly related to the total charge of the ligand anion.
1.Introduction
Bisphosphonates (BPs) represent a very important class of
compounds known for their medicinal and other properties
[1, 2]. In contrast to the naturally occurring pyrophosphate
P-O-P group, these compounds contain a characteristic P-
C-P bridge, which is chemically and enzymatically nonhy-
drolyzable. BPs exhibit speciﬁc aﬃnity towards bone, which
makes them an excellent therapeutic for bone resorption
diseases (especially osteoporosis, Paget’s disease, tumour
induced osteolysis, hypercalcemia originated from malig-
nancy)byinhibitionoffarnesyldiphosphatesynthase(FPPS)
and for bone tumour caused by metastatic breast tumours
[3–5]. The biological activity of bisphosphonates has been
found to be dependent on the structure [6], lipophilicity
[7], and bone binding aﬃnity [8] of the compounds. For
example,thestructureofthesidechainofbisphosphonatesis
important in determining the potency of individual bispho-
sphonates in biological models, and this includes a potential
role for the side chain in modulating bone binding. The
presence and position of an oxygen or nitrogen atom within
the side chain of bisphosphonates are directly related to their
relative potency and bone binding aﬃnity. In general, the
oxygen/nitrogen containing bisphosphonates exhibits high
bone binding aﬃnities, which might be expected to reduce
eﬃcacy. However, some of these molecules are very potent
and the diﬀerence in potency has been attributed to the
inhibitionofFPPS.Therefore,thestructuralcharacterization
of bisphosphonates is very important tool for the elucidation
of the mechanisms of the bone binding and biological
activity and for the design of new, more potent compounds.
Herein, we report the synthesis, solution character-
ization, and crystal structure of the sodium salt of
tetrahydrofuranyl-2,2-bisphosphonate (Na2H2L). In the
crystal the compound forms, the unusual for bisphos-
phonates, two-dimensional parallel sheets arrangement. A
comparison of the chelating properties of H2L2− with
similar hydroxyl bisphosphonate ligands shows that the Na–
O(furanyl/hydroxyl) bond length increases as the charge
of the ligand decreases. Thus, the weak Na–O(furanyl)
interaction is attributed to the −2 charge of the ligand.
2.MaterialsandMethods
2.1. Materials. The chemicals obtained from commercial
sources were reagents grade and used as received. Solvents2 Bioinorganic Chemistry and Applications
were freshly distilled and water was doubly distilled. γ-
Chlorobutyric acid, phosphorus acid, and D2Ow e r ep u r -
chased from Sigma-Aldrich. Sodium hydroxide and phos-
phorustrichloridewerepurchasedfromMerck.Ethylalcohol
and methyl alcohol were bought from BDH. The synthesis
was performed in inert Argon atmosphere.
2.2. Synthesis and Crystallization of Tetrahydrofuranyl-2,2-
Bisphosphonic Acid Disodium Salt (Na2H2L). Am i x t u r eo f
γ-chlorobutyric acid (7.12g, 58.1mmol), phosphorus acid
(3.38g, 41.2mmol), and phosphorus trichloride (10.9g,
79.4mmol) was heated slowly to reach the temperature 80
◦C
over an hour under constant ﬂow of argon. The two-phase
mixture was reﬂuxed for 4 hours at 80
◦C and the viscous
yellow mass was stirred vigorously for 10 hours at 60
◦C.
Precooled water (125mL) was added slowly to the mixture
under stirring as evolution of gaseous HCl was observed.
The water (110mL) was constantly removed by distillation
from the orange reaction mass. Another 150mL of water was
added to the mixture and allowed to cool down slowly to
room temperature (25
◦C). The pH of the reaction mixture
was adjusted to 3 by careful addition of 4 M NaOH solution.
Absolute ethyl alcohol (150mL) was poured slowly to the
resulting yellow solution in order to induce crystallisation.
White solid was formed after 12 hours stirring at 25
◦C
and collected by ﬁltration. The yellow ﬁltrate was again
treated with ethyl alcohol (100mL) to obtain another batch
of white solid. Total three batches were collected and for
the crude product the yield was calculated to be 9.75g,
(65% based on γ-chlorobutyric acid). Crystallisation was
performed by layering concentrated aqueous solution (pH
= 4.2) of Na2H2L with methyl alcohol. Samples for NMR
measurements were prepared by dissolution of the crystals
in D2O. The atoms have been numbered according to the
numbering in Scheme 1. 1HN M Rδ(D2O, ppm): 3.90 (t,
2JH,H = 6.7Hz, two protons H(4)); 2.30 (m, 2JH,H = 6.7Hz,
3JH,P = 16.0Hz, two protons, H(2)); 1.99 (p, 2JH,H = 6.7Hz,
two protons H(3)). 13CN M Rδ(D2O, ppm): 81.3 (t, 1JC,P =
144Hz),C(1);70.3,C(4);30.2,C(3);26.8(t, 2JC,P =2.26Hz),
C(2). 31PN M Rδ(D2O, ppm): 21.9 (t, 3JH,P = 16.0Hz). Anal.
Calcd. for C4H8Na2O7P2 (f.w.: 276.02): C, 17.41; H, 2.92.
Found: C, 17.38; H, 2.89.
2.3. NMR Studies. The one-dimensional 1H, 13C, and 31P
spectra were recorded in a 300MHz Avance Bruker spec-
trophotometer at 300.13MHz for 1H, 121.46MHz for 31P,
and 75.47MHz for 13Cw i t ha5m mm u l t i n u c l e u sp r o b ea t
ambient temperature (25
◦C) in D2O solution. A 30
◦-pulse
width and 1-second relaxation delay were applied for 1H,
31P, and 13CN M Rs p e c t r a .
2.4. X-Ray Crystallography. Crystal data, details of data
collection, and reﬁnement of crystal structure of Na2H2La r e
provided in Table 1. The intensity data for the compound
werecollectedat100KonanXCaliburIII4-cyclediﬀractome-
ter, equipped with a CCD camera detector. The experimental
datawerecollectedusingMoKαradiation(λ =0.7107 ˚ A)ata
crystal-to-detector distance 60mm. The structure was solved
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Scheme 1: Synthetic methodology for synthesis of Na2H2La l o n g
withthenumberingschemeofC-atomsforNMRpeakassignments.
Table 1: Crystallographic and experimental data for compound
Na2H2L.a, b
Empirical formula C4H6Na2O7P2
Formula mass 274.01
Crystal system Triclinic
Space group P-1
a/˚ A 6.327 (5)
b/˚ A 6.967 (5)
c/˚ A 11.805 (5)
α/◦ 93.067 (5)
β/◦ 96.222 (5)
γ/◦ 113.594 (5)
V/˚ A3 471.4 (5)
Z 2
Dc/gcm−3 1.930
Absorption coeﬃcient/cm−1 0.564
F (000) 276
θ range for data collection/◦ 3.7788–62.3061
−7 ≤ h ≤ 7
Ranges for h, k, l −8 ≤ h ≤ 7
−11 ≤ h ≤ 13
Reﬂections collected/unique 2384/1451
Rint 0.0218
Data/restraints/parameters 3667/0/171
GOF on F2 1.158
a, b in weighting scheme 0.1390/0.0668
Final R/Rw indices (I>2σ(I)) 0.0572/0.2162
Final R/Rw indices (all data) 0.0827/0.2288
aAll structures determined at T = 100K using Mo Kα radiation (λ =
0.71073 ˚ A).
bR = Σ Fo|−| Fc /Σ|Fo|, wR = [Σw(|Fo|2 −|Fc|2)/Σw|Fo|2]
1/2
,G O F=
[Σ[w(F2
o −F2
c )
2]/(n − p)]
1/2
, w = 1/[σ2(F2
o)+( aP)2 + bP], where P =
(F2
o +2F2
c )/3.
by direct methods using the programs SHELXS-86 and
reﬁned anisotropically (nonhydrogen atoms) by full-matrix
least squares on F2 [9, 10] .T h eHa t o m sw e r ec a l c u l a t e d
geometrically and reﬁned with riding model with isotropic
displacement parameters. The programs ORTEP-3 [11]a n d
Diamond-3 were used for diagrams and WINGX [12]w a s
used to prepare material for publication.Bioinorganic Chemistry and Applications 3
3. Results andDiscussion
3.1. Synthesis. Compound Na2H2L has been synthesized by
heating at 80
◦C the mixture of γ-chlorobutyric acid, phos-
phorus acid, and phosphorus trichloride (Scheme 1). This
molecule has been previously synthesized by Kieczykowski et
al. [13] following a similar procedure by heating the mixture
at 65
◦C in methanesulfonic acid. However, the product
isolated from that reaction had always been contaminated
with the methanesulfonate salt and the yield of the reaction
was less than 30%. In contrast, the reaction without the use
ofsolventgavepureproductandyieldmorethan60%.Upon
completion of the reaction, it is quenched with water. The
productwascrystallizedbyadditionofethanolinanaqueous
solution of Na2H2L at pH 3.0. It is worth to notice that the
isolated compound is the disodium salt of the bisphospho-
nateanionalthoughithasbeenisolatedatpHlowerthanthat
of the monosodium salt (pH 4.3) by Kieczykowski et al. This
diﬀerence is attributed to the diﬀerent methodology used for
the crystallization of the product.
3.2. Solution Characterization. The molecule was charac-
terized in aqueous solution by 1H, 13C, and 31PN M R
spectroscopy. The J coupling constants were used to conﬁrm
the assignments made by the NMR spectra. The 31PN M R
spectrum gave one triplet due to the coupling (3JHP =
16.0Hz) of phosphorus nuclei with the two H(2) protons at
21.9ppm. This chemical shift is close to the chemical shifts
of other hydroxyl bisphosphonates such as etidronate (L1,
Scheme 2) (22.9ppm) [14]. The 13Cs p e c t r u mo fN a 2H2L
showed a triplet assigned to C(1). The splitting of this peak
is assigned to the strong coupling of C(1) with the two
phosphorus atoms (1JCP = 144.0Hz). The weak coupling of
C(2) with the two phosphorus nuclei (2JC,P = 2.26Hz) gives
a triplet feature for this peak that can be easily distinguished
from the peak assigned to C(3). The 1HN M Rs p e c t r u m
exhibits a triplet for H(4) protons (due to the coupling with
the two H(3) protons), a quintuplet for H(3) (due to the
coupling with the two H(2) and two H(4) protons), and a
multiplet for H(2) (due to the coupling with the two H(3)
protons and the two P atoms).
3.3. X-Ray Crystallographic Structure. The molecular struc-
ture of Na2H2L is shown in Figures 1 and 2(a).C r y s -
tallographic data are provided in Table 1. Tables 3 and
4 contain the interatomic bond lengths and angles of
Na2H2L. The bisphosphonate anion in the structure of
Na2H2L possesses an overall −2 charge, thus two of the
phosphonate oxygen atoms are deprotonated (P–O
−), two
have protons attached (P–OH), and two form double bond
with phosphorous (P=O). Both phosphorous atoms exhibit
distorted tetrahedral geometries. The P–O bond lengths are
close to 1.50 ˚ A for the P-O(deprotonated) and 1.57 ˚ Af o r
the P–OH(protonated). Although the P–OH bonds can be
locatedveryeasilybyinspectionofthebonddistances,theP–
O
− and P=O cannot be distinguished because of the charge
delocalization over the
−O–P=O groups. The bond angles
around P(1), P(2) range from 104.0(4) to 116.4(3)◦.T h eO –
P–O angles involving the two unprotonated oxygen atoms
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Scheme 2: Molecular structures of etidronate, pamidronate, and
alendronate and abbreviations used in the document.
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Figure 1: ORTEP representation of the main structural motif
observed in Na2H2L. Ellipsoids are drawn at the 50% probability
level.
are the largest ones in both phosphonate groups. The two
phosphorus centers are fairly close (3.087(3) ˚ A), due to their
bisectional positions relative to C(1) on the furanyl ring
(P(1)–C(1)–P(2) = 114.7(5)◦). The P...P distance is a little
larger than the distance (3.035(3) ˚ A) observed in the crystal
structure of nitrogen containing respective molecule, the
pyrrolidine-2,2-diylbisphosphonic acid [15].
The coordination sphere is diﬀerent for each of the two
sodium atoms (Figures 3(a) and 3(b)). The Na(1) exhibits
a distorted octahedral environment deﬁned by O(5), O(4),
O(2), O(6), O(3), and O(3 ). The Na(2) exhibits a capped
octahedral geometry with the O(1), O(2), O(3), O(5), O(6),
and O(6 ) to deﬁne an octahedron and the O(7) added to the
triangular face deﬁned by O(1), O(3), and O(6). The Na–O
bond distances range between 2.327(7) and 2.872(7) ˚ Aw i t h
the Na(2)–O(7) to exhibit the longest bond distance. The
sodium-centered octahedrons and capped octahedrons form4 Bioinorganic Chemistry and Applications
Table 2: Selected bond lengths (˚ A) for Na2H2L.
C(1)–O(1) 1.48 (2) P(1)–O(2) 1.571 (8)
C(1)–C(2) 1.50 (2) P(1)–O(3) 1.499 (7)
C(2)–C(3) 1.59 (3) P(1)–O(4) 1.499 (5)
C(3)–C(4) 1.50 (4)
C(4)–O(1) 1.42 (2) P(2)–O(5) 1.507 (7)
C(1)–P(1) 1.834 (9) P(2)–O(6) 1.493 (7)
C(1)–P(2) 1.833 (7) P(2)–O(7) 1.567 (7)
Na(1)–O(2) 2.625 (7) Na(2)–O(1) 2.79 (2)
Na(1)–O(3) 2.335 (7) Na(2)–O(2) 2.494 (8)
Na(1)–O(3 ) 2.671 (8) Na(2)–O(3) 2.371 (7)
Na(1)–O(4) 2.449 (8) Na(2)–O(5) 2.405 (7)
Na(1)–O(5) 2.480 (7) Na(2)–O(6) 2.423 (8)
Na(1)–O(6) 2.327 (7) Na(2)–O(6 ) 2.458 (6)
aStandard deviations are given in parentheses.
bSymmetry operations: x, y, z; −x, −y, −z.
Table 3: Selected bond angles (◦)f o rN a 2H2L.
O(2)–P(1)–O(3) 110.7 (3) O(5)–P(2)–O(6) 115.1 (3)
O(2)–P(1)–O(4) 105.5 (3) O(5)–P(2)–O(7) 110.1 (4)
O(3)–P(1)–O(4) 116.4 (4) O(6)–P(2)–O(7) 109.3 (4)
C(1)–P(1)–O(2) 105.2 (4) C(1)–P(2)–O(5) 108.6 (4)
C(1)–P(1)–O(3) 110.9 (4) C(1)–P(2)–O(6) 109.2 (4)
C(1)–P(1)–O(4) 107.4 (4) C(1)–P(2)–O(7) 104.0 (4)
O(1)–C(1)–P(1) 106.5 (6) O(1)–C(1)–P(2) 105.2 (6)
C(2)–C(1)–P(1) 107.9 (8) C(2)–C(1)–P(2) 110.7 (8)
O(1)–C(1)–C(2) 112.0 (9) P(1)–C(1)–P(2) 114.6 (5)
C(1)–O(1)–C(4) 105 (1) C(1)–C(2)–C(3) 100 (1)
O(1)–C(4)–C(3) 107 (2) C(2)–C(3)–C(4) 103 (2)
aStandard deviations are given in parentheses.
bSymmetry operations: x, y, z; −x, −y, −z.
Table 4: Selected bond lengths for Na
+ and Ca
2+ bisphosphonate complexes. The L, L1, L2, L3 bisphosphonates are according to Scheme 2.
Compound Charge of
bisphosphonate anion M–Ohydroxy/furanyl/˚ A Shortest
M–Ophosporyl/˚ A
Longest
M–Ophosporyl/˚ A
References
Na2H2L (−2) 2.79 (1) 2.327 (7) 2.873 (8) This work
CaH2L1 (−2) 2.608 (2) 2.352 (1) 2.608 (2) [16]
NaH3L1 (−1) 2.470 (4) 2.230 (4) 2.447 (4) [17]
NaH3L1 (−1) 2.463 (2) 2.293 (3) 2.444 (2) [18]
CaH2L2 (−2) a 2.288 (1) 2.387 (1) [19]
Na2H2L2 (−2) 2.828 (3) 2.274 (3) 2.691 (3) [20]
NaH3L2 (−1) 2.537 (2) 2.261 (2) 2.438 (2) [21]
CaH2L3 (−2) a 2.304 (1) 2.345 (1) [22]
a Non bonding distance above 3
 
˚ A.
an edge-sharing linear array directed along the axis (1,1,0)
of the crystal (Figure 3(a)) .T h e s ea r r a y sa r ec o n n e c t e dt o
each other with the diphosphonate anions (Figure 3(b))
forming inﬁnite 2D sheets. The two-dimensional networks
are stacked one over the other along axis c (Figure 3(c)).
The distance between the mean planes deﬁned from the
atoms of two successive sheets is 11.668(5) ˚ A. This distance
is actually the length of the c axis. The furanyl rings are
located above and below the 2D structures insulating the
sodium ions in each layer. It is possible that this unusual forBioinorganic Chemistry and Applications 5
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Figure 2: (a) Stick representation of H2L
2− showing the connectiv-
ity with sodium ions. (b) Stick representation of Na2H2L showing
the coordination environment of sodium ions.
diphosphonates two-dimensional structure is induced by the
hydrophobic furanyl rings which prevent any electrostatic
interlayer interactions.
Ar e c e n ts t u d y[ 23] has shown that bisphosphonates
binding strength can be calculated by summarizing the
interactions of the phosphonate groups, the side chain
groups, the hydroxyl group, and the hydrophobic group of
the ligand with the bone surface. Most importantly, it has
beenfoundthatalthoughthe −OHgroupisnecessaryforthe
strong binding of phosphonates on the bone, the interaction
of the −OH with the bone surface is weak. Selected bond
lengths of Na+–O/Ca2+–O of similar tetrahydrofuranyl-2,2-
bisphosphonate compounds extracted from their crystal
structure are shown in Table 4. The comparison shows
that the chelating properties of the ligands are in good
agreement with their binding properties on bone surface.
Thus, the bond distances between the donor oxygen atoms
of bisphosphonate ligand and the cations might give an
estimation of the bisphosphonates bone binding strength.
The (Na+/Ca2+)–O(phosphoryl) bond distances are similar,
Na1
Na1
Na1
Na2
Na1 Na2
Na2
Na2
Na1
(a)
(b)
(c)
Figure 3: (a) Sodium-centered polyhedral connected to each other
to form linear arrays along axis (1,1,0). (b) Connection of the
linear sodium arrays with bisphosphonate anions to form two
dimensional sheets. (c) Two layers stacked one parallel to the other
along axis c.6 Bioinorganic Chemistry and Applications
within the range 2.261 to 2.873 ˚ A, suggesting that the
interaction of all phosphonate groups with the bone is of
similar strength for all ligands. In all crystal structures of the
calcium salts of the bisphoshonates, except the structure of
etidronate, the metal ion is ligated only to the phosphonate
oxygen atoms. The charge of the ligand in all calcium
structures is −2. In contrast, the Na+ ions have been found
to be ligated both to the phosphonate and the hydroxyl
oxygen in the structures of the sodium salts of the respective
ligands. However, the Na+–O bond length is much shorter
in the structures of monoanion bisphosphonate structures
(∼2.5 ˚ A) than in the respective dianions (∼2.8 ˚ A) including
Na2H2L. Apparently, this bond length comparison indicates
that the Na+–O(hydroxyl/furanyl) bond strength is directly
dependent on the total charge of the bisphosphonate ligand;
the bond length increases by decreasing the charge of the
ligand. In addition, the weak interaction of hydroxyl group
with the bone [23] also suggests that the total charge of the
ligand that binds the bone surface is −2.
The Na+–O bond distances found in the crystal structure
of Na2H2L are close to the respective bond distance of
Na2H2L2 (L2 = pamidronate, Scheme 2) showing that the
contribution of these bonds for bone binding is similar [20].
However, the tetrahydrofuranyl side chain does not contain
any group that will contribute to the bone binding, thus it
is expected that H2L2− will be a weaker bone binder than
H2L12−,H 2L22−,a n dH 2L32− (Scheme 2).
4. Conclusions
The tetrahydrofuranyl-2,2-bisphosphonic acid has been pre-
pared with an eﬃcient method without the use of solvent,
producing pure product in high yield over 60%. The crystal
structure of the complex showed that the disodium salt of
bisphosphonate crystallizes forming two-dimensional sheets
stacked parallel one over the other.
The results of this study show that the crystallographic
characterization of a widely used class of drug molecules,
the bisphosphonate salts, provide important information on
their biological activity (bone binding, FPPS inhibition),
and can be used for the design of new more active
molecules. The bisphosphonates binding strength with bone
can be calculated by summarizing the interactions of the
phosphonate groups, the side chain groups, the hydroxyl
group, and the hydrophobic group of the ligand with the
bone surface. The crystallographic data of the Na+/Ca2+ salts
of bisphosphonate show that the interaction of the –OH
group with the metal ions is weak which is in agreement with
the results from a recent study [23] on the interaction of the
bisphosphonates with bone surface. Furthermore a compar-
ison of Na+/Ca2+ bisphosphonate structures shows that the
strength of the Na–O(hydroxyl/furanyl) bond reduces with
the decrease of the total bisphosphonate anion charge.
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